Latest

A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Updated 04 Jul 2026 · HPRA open data

Ipsen Pharmaceuticals Limited — Licensed Medicines

7 medicines held by Ipsen Pharmaceuticals Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 7 products held by Ipsen Pharmaceuticals Limited

Medicine	Active substance	Licence holder	Status
Decapeptyl 3-month, 11.25 mgPowder and solvent for suspension for injection PA0869/003/002	Triptorelin	Ipsen Pharmaceuticals Limited	Marketed
Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PA0869/003/003	Triptorelin pamoate	Ipsen Pharmaceuticals Limited	Marketed
Decapeptyl SR, 3 mg powder and solvent for suspension for injection PA0869/003/001	Triptorelin	Ipsen Pharmaceuticals Limited	Marketed
Salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection PA0869/008/001	Triptorelin	Ipsen Pharmaceuticals Limited	Not marketed
Somatuline Autogel 120mg, solution for injection in a pre-filled syringe PA0869/004/004	Lanreotide acetate	Ipsen Pharmaceuticals Limited	Marketed
Somatuline Autogel 60 mg, solution for injection in a prefilled syringe PA0869/004/002	Lanreotide acetate	Ipsen Pharmaceuticals Limited	Marketed
Somatuline Autogel 90mg, solution for injection in a pre-filled syringe PA0869/004/003	Lanreotide acetate	Ipsen Pharmaceuticals Limited	Marketed

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.